![James B. Dougherty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James B. Dougherty
Gründer bei
Arcus Ventures
Profil
James B. Dougherty is the founder of Arcus Ventures, which was founded in 2007.
He holds the title of General Partner at Arcus Ventures starting in 2011.
Dr. Dougherty currently holds the position of Director at Molecular Imaging, Inc., Director at The Lung Cancer Research Foundation, and Venture Partner at Cross Atlantic Partners, Inc. Dr. Dougherty has previously held the position of Director at Oncoscope, Inc. and Clear Vascular, Inc. He also served as Deputy Physician-in-Chief at Memorial Sloan Kettering Cancer Center from 1997 to 2001.
Dr. Dougherty's education includes an undergraduate degree from Georgetown University in 1976, a doctorate from Hershey Medical Center, and an MBA from The Wharton School of the University of Pennsylvania in 1997.
Aktive Positionen von James B. Dougherty
| Unternehmen | Position | Beginn |
|---|---|---|
Cross Atlantic Partners, Inc.
 Cross Atlantic Partners, Inc. Investment ManagersFinance Cross Atlantic focuses only on US-based healthcare opportunities, especially in drug discovery, devices and services. They place emphasis on oncology, neurological diseases and infectious diseases. They look for companies seeking to develop more effective, less expensive products or services which reduce the need for surgery or hospitalization and provide higher quality care at a lower cost. Cross Atlantic invests in companies beyond the start-up stage. They seek companies whose innovative products show clear competitive advantages. Such products should be based on proprietary technology or specialized service expertise and should meet significant market needs. In-depth review of patent portfolios is a standard part of their due diligence. The firm expects at least a 3X return of capital with an average holding period of 4 years. Exit strategies may include the sale of securities through IPOs, secondary public and private offerings, sales in connection with strategic alliance/corporate partnering transactions or merger and acquisition transactions. | Private Equity Investor | 18.09.2012 |
Arcus Ventures
 Arcus Ventures Investment ManagersFinance Arcus Ventures invests in companies located in the United States. The firm targets companies operating in the fields of healthcare services and medical devices. It provides financing for early stage capital requirements. | Gründer | 05.01.2011 |
Molecular Imaging, Inc.
 Molecular Imaging, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research services supported by extensive in vivo imaging capabilities | Direktor/Vorstandsmitglied | - |
The Lung Cancer Research Foundation
 The Lung Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Provides funding to cancer research centers | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von James B. Dougherty
| Unternehmen | Position | Ende |
|---|---|---|
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Corporate Officer/Principal | 31.12.2001 |
Clear Vascular, Inc.
 Clear Vascular, Inc. Pharmaceuticals: MajorHealth Technology Develops radionuclide products for multiple clinical applications | Direktor/Vorstandsmitglied | - |
Oncoscope, Inc.
 Oncoscope, Inc. Medical/Nursing ServicesHealth Services Develops optical imaging systems for the early detection of cancers | Direktor/Vorstandsmitglied | - |
Ausbildung von James B. Dougherty
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Oncoscope, Inc.
Oncoscope, Inc. Medical/Nursing ServicesHealth Services Develops optical imaging systems for the early detection of cancers | Health Services |
Cross Atlantic Partners, Inc.
Cross Atlantic Partners, Inc. Investment ManagersFinance Cross Atlantic focuses only on US-based healthcare opportunities, especially in drug discovery, devices and services. They place emphasis on oncology, neurological diseases and infectious diseases. They look for companies seeking to develop more effective, less expensive products or services which reduce the need for surgery or hospitalization and provide higher quality care at a lower cost. Cross Atlantic invests in companies beyond the start-up stage. They seek companies whose innovative products show clear competitive advantages. Such products should be based on proprietary technology or specialized service expertise and should meet significant market needs. In-depth review of patent portfolios is a standard part of their due diligence. The firm expects at least a 3X return of capital with an average holding period of 4 years. Exit strategies may include the sale of securities through IPOs, secondary public and private offerings, sales in connection with strategic alliance/corporate partnering transactions or merger and acquisition transactions. | Finance |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Health Services |
Clear Vascular, Inc.
Clear Vascular, Inc. Pharmaceuticals: MajorHealth Technology Develops radionuclide products for multiple clinical applications | Health Technology |
Arcus Ventures
Arcus Ventures Investment ManagersFinance Arcus Ventures invests in companies located in the United States. The firm targets companies operating in the fields of healthcare services and medical devices. It provides financing for early stage capital requirements. | Finance |
Molecular Imaging, Inc.
Molecular Imaging, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research services supported by extensive in vivo imaging capabilities | Commercial Services |
Hershey Medical Center
 Hershey Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Lung Cancer Research Foundation
The Lung Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Provides funding to cancer research centers | Commercial Services |
